New York, NY (PRWEB) January 31, 2013
The prescription drug resource center DrugRisk.com is alerting women using the vaginal ring contraceptive NuvaRing of new information added to the site showing the number of blood clot claims has increased in recent months. This, as a leading research group, added new warnings for the device.
“DrugRisk’s goal is to improve patient safety through education of the latest drug warnings, recalls, studies and litigation news. Well-informed patients can better discuss their side effect options with their doctor and decide if they need to seek legal advice,” explains DrugRisk representative Ryan Mayer.
The resource center has added warnings from health experts that link vaginal ring contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills.
The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives.* On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.**
This month, DrugRisk learned of research at Brigham and Women’s Faulkner Hospital that found that, while combined hormone vaginal ring contraceptives like NuvaRing can increase blood clot risks for all women, the risks are significantly higher for those suffering migraines.***
DrugRisk has also learned that, due to the number of patients filing a NuvaRing lawsuit, cases have been consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.
Now, new information on the site from the federal joint panel on multidistrict litigation shows the number of NuvaRing lawsuits filed has risen nearly 5% in recent months to 1,129.**** This comes as the trial date of July 8, 2013 set by Judge Rodney Sippel approaches.*****
Anyone who suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.
Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
*****Order # 1423, Novenber 20, 2012, Case: 4:08-md-01964-RWS